Information:
Fel:
ID
34410
Beskrivning
Dalfampridine for Imbalance in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01444300
Länk
https://clinicaltrials.gov/show/NCT01444300
Nyckelord
Versioner (1)
- 2019-01-17 2019-01-17 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
17 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Multiple Sclerosis NCT01444300
Eligibility Multiple Sclerosis NCT01444300
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT01444300
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
age 20- 59 years,
boolean
ID.2
Item
able to walk at least 100m without an aide or with unilateral assistance
boolean
ID.3
Item
prolonged apr latencies (≥ 1sd > mean for healthy people in this age range) or,
boolean
ID.4
Item
reduced balance-related activity (abc scores ≤ 85%),
boolean
ID.5
Item
abnormal trunk range of motion (horizontal), trunk range of motion (frontal), turning duration, cadence, double support time, stride length or gait cycle time (outside 1sd of the average for healthy people in this age range)
boolean
ID.6
Item
currently taking dalfampridine (any within the last 2 weeks),
boolean
ID.7
Item
cause(s) of imbalance other than ms,
boolean
ID.8
Item
impaired renal function (creatinine clearance ≤50ml/min),
boolean
ID.9
Item
seizure disorder
boolean
ID.10
Item
pregnancy or breast feeding
boolean